Related Experiment Videos
Leiomyosarcomas of the extremities
1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Journal of Surgical Oncology
|January 1, 1989
Summary
Leiomyosarcomas, rare extremity cancers, often recur after surgery, leading to poor prognoses. Aggressive, multidisciplinary treatment is crucial for improving outcomes in these uncommon malignant neoplasms.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Leiomyosarcomas are rare malignant neoplasms.
- Extremity leiomyosarcomas are particularly uncommon.
- These tumors present unique clinical challenges.
Purpose of the Study:
- To describe the clinical characteristics of extremity leiomyosarcomas.
- To analyze treatment outcomes and survival.
- To advocate for improved management strategies.
Main Methods:
- Retrospective review of 17 extremity leiomyosarcoma cases.
- Analysis of clinical data from Memorial Sloan-Kettering Cancer Center.
- Follow-up over a 32-year period.
Main Results:
- Most tumors occurred in the lower extremities.
- High rates of recurrence were observed, including late recurrences.
- Median survival was 24 months, indicating a grim prognosis.
Conclusions:
- Extremity leiomyosarcomas have a poor prognosis with current standard treatments.
- Recurrence after surgery alone is common.
- More aggressive, multidisciplinary approaches are necessary for better patient outcomes.